Market Value205,558,000
Total Holdings75
File Date2018-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ATRC / AtriCure, Inc.
NLTX / Neoleukin Therapeutics, Inc.
US750469AA69 / Radius Health, Inc. Bond
YMTX / Yumanity Therapeutics Inc
FOMX / Foamix Pharmaceuticals Ltd.
EXAC / Exactech, Inc.
45784PAG6 / Insulet Corp Bond
VSCI /
LOXO / Loxo Oncology, Inc.
ZGNX / Zogenix Inc
US55027E1029 / Luminex Corporation
AGTC / Applied Genetic Technologies Corp
ARQL / ArQule, Inc.
SRRA / Sierra Oncology Inc
NERV / Minerva Neurosciences, Inc.
COGT / Cogent Biosciences, Inc.
VIRX / Viracta Therapeutics, Inc.
IMDZ / Immune Design Corp.
BVXV / Biondvax Pharmaceuticals Ltd - ADR
BLCM / Bellicum Pharmaceuticals, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
JNJ / Johnson & Johnson
ALDR / Alder BioPharmaceuticals, Inc.
VYGR / Voyager Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc
GEMP / Gemphire Therapeutics Inc.
US64052L1061 / Neos Therapeutics, Inc.
LPTX / Leap Therapeutics, Inc.
CMTA / Clementia Pharmaceuticals Inc.
US46333XAD03 / Ironwood Pharmaceuticals, Inc. DBCV 2.250% 6/1
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
24983LAA2 / Dermira Inc Bond
DERM / Journey Medical Corporation
NXTM / NxStage Medical, Inc.
SLGL / Sol-Gel Technologies Ltd.
VBIV / VBI Vaccines Inc.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
252131AE7 / Dexcom Inc Bond
US00448Q2012 / Achillion Pharmaceuticals, Inc.
OBSV / ObsEva SA.
US0906721065 / BioTelemetry, Inc.
SCPH / scPharmaceuticals Inc.
INCY / Incyte Corporation
CLSD / Clearside Biomedical, Inc.
/ Immunomedics, Inc.
MGNX / MacroGenics, Inc.
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
CASC / Cascadian Therapeutics, Inc.
NTUS / Natus Medical Inc
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
AERI / Aerie Pharmaceuticals Inc
ARNA / Arena Pharmaceuticals Inc
RDUS / Radius Recycling, Inc.
WVE / Wave Life Sciences Ltd.
PDSB / PDS Biotechnology Corporation
URGN / UroGen Pharma Ltd.
US014339AA35 / Alder Biopharmaceuticals Inc Bond
AKBA / Akebia Therapeutics, Inc.
SCYX / SCYNEXIS, Inc.
ARDX / Ardelyx, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
ARGX / argenx SE - Depositary Receipt (Common Stock)
BLUE / bluebird bio, Inc.
CARA / Cara Therapeutics, Inc.
TNDM / Tandem Diabetes Care, Inc.
CBAY / CymaBay Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
XENE / Xenon Pharmaceuticals Inc.
CDTX / Cidara Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
MASI / Masimo Corporation
RIGL / Rigel Pharmaceuticals, Inc.
NBIX / Neurocrine Biosciences, Inc.
LCTX / Lineage Cell Therapeutics, Inc.
DXCM / DexCom, Inc.
RCUS / Arcus Biosciences, Inc.
STXS / Stereotaxis, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
PRQR / ProQR Therapeutics N.V.
PODD / Insulet Corporation
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
SPRO / Spero Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation